Search jobs 10-Dec-2020 CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications REHOVOT, Israel and VANCOUVER, BC, Dec. 10, 2020 /PRNewswire/ CollPlant (NASDAQ: CLGN), a regenerative medicine company, and STEMCELL Technologies, Canada s largest privately owned biotechnology company, which develops cell culture media, cell separation systems, instruments, and other reagents for life sciences research, today jointly announced they have entered into a product manufacturing and supply agreement. CollPlant will sell its proprietary recombinant human Type I collagen (rhCollagen), the world s first plant-based rhCollagen, to STEMCELL Technologies, which will incorporate CollPlant s product into cell culture media kits.
CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications
USA - English
News provided by
Share this article
Share this article
REHOVOT, Israel and VANCOUVER, BC, Dec. 10, 2020 /PRNewswire/ CollPlant (NASDAQ: CLGN), a regenerative medicine company, and STEMCELL Technologies, Canada s largest privately owned biotechnology company, which develops cell culture media, cell separation systems, instruments, and other reagents for life sciences research, today jointly announced they have entered into a product manufacturing and supply agreement. CollPlant will sell its proprietary recombinant human Type I collagen (rhCollagen), the world s first plant-based rhCollagen, to STEMCELL Technologies, which will incorporate CollPlant s product into cell culture media kits.